These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9750683)

  • 1. [Implanted automatic defibrillator after ventricular fibrillation treated with semi-automatic defibrillation].
    Ould-Ahmed M; Bordier E; Leenhardt A; Frank R; Michel A
    Ann Fr Anesth Reanim; 1998; 17(1):47-51. PubMed ID: 9750683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful implantation of cardioverter-defibrillator systems in patients with elevated defibrillation thresholds.
    Brooks R; Torchiana D; Vlahakes GJ; Ruskin JN; McGovern BA; Garan H
    J Am Coll Cardiol; 1993 Aug; 22(2):569-74. PubMed ID: 8335831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of defibrillation testing at the time of implantable cardioverter-defibrillator insertion.
    Hadid C; Atienza F; Strasberg B; Arenal Á; Codner P; González-Torrecilla E; Datino T; Percal T; Almendral J; Ortiz M; Martins R; Martinez-Alzamora N; Fernandez Aviles F
    Cardiol J; 2015; 22(3):253-9. PubMed ID: 25179316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of defibrillation testing.
    Amit G; Healey JS
    Card Electrophysiol Clin; 2015 Sep; 7(3):539-46. PubMed ID: 26304533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the implantable cardioverter-defibrillator on rehospitalizations.
    Valenti R; Schlåpfer J; Fromer M; Fischer A; Kappenberger L
    Eur Heart J; 1996 Oct; 17(10):1565-71. PubMed ID: 8909915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An appropriate defibrillation threshold obtained by the combined connection between two shock leads and ICD generator.
    Sato A; Chinushi M; Iijima K; Watanabe H; Izumi D; Furushima H; Sonoda K; Hasegawa K; Yagihara N; Aizawa Y
    Intern Med; 2011; 50(22):2815-8. PubMed ID: 22082895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
    Saksena S; Tullo NG; Krol RB; Mauro AM
    Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How implantable cardioverter-defibrillators work and simple programming.
    Bryant RM
    Cardiol Young; 2017 Jan; 27(S1):S121-S125. PubMed ID: 28084970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between manual mode defibrillation, pre-shock pause duration and appropriate shock delivery when employed by basic life support paramedics during out-of-hospital cardiac arrest.
    Cheskes S; Hillier M; Byers A; Verbeek PR; Drennan IR; Zhan C; Morrison LJ
    Resuscitation; 2015 May; 90():61-6. PubMed ID: 25737080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Estimation of defibrillation threshold using abdominally implanted cardioverter-defibrillator with an additional defibrillation pole in a dual-coil lead endocardial defibrillation system].
    Pazdyga A; Lubiński A; Lewicka-Nowak E; Królak T; Kempa M; Zienciuk A; Raczak G
    Pol Merkur Lekarski; 2007 Feb; 22(128):86-9. PubMed ID: 17598649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias.
    Ricci R; Pignalberi C; Disertori M; Capucci A; Padeletti L; Botto G; Toscano S; Miraglia F; Grammatico A; Santini M
    Eur Heart J; 2002 Sep; 23(18):1471-9. PubMed ID: 12208228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry.
    Ellenbogen KA; Koneru JN; Sharma PS; Deshpande S; Wan C; Szymkiewicz SJ
    JACC Clin Electrophysiol; 2017 Mar; 3(3):243-250. PubMed ID: 29759518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Low energy cardioversion with the implantable cardioversion defibrillator devices for treatment of ventricular tachycardia and ventricular fibrillation].
    Siebels J; Schneider MA; Kuck KH
    Z Kardiol; 1993 Nov; 82(11):683-91. PubMed ID: 8291289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Train tracks" and "step ladders" on implantable cardioverter defibrillator interval plot in a patient with dual tachycardia: Putting the dots together.
    Saini A; Ellenbogen KA; Tan A; Kaszala K; Huizar JF
    Pacing Clin Electrophysiol; 2017 Nov; 40(11):1298-1301. PubMed ID: 28901551
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in implantable cardioverter-defibrillator therapy.
    Raitt MH; Bardy GH
    Curr Opin Cardiol; 1994 Jan; 9(1):23-9. PubMed ID: 8199367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical aspects of automatic implantable cardioverter defibrillator (AICD) in patients with life-threatening ventricular tachyarrhythmias].
    Matsui Y; Shiiya N; Murashita T; Miyama M; Oba J; Gohda T; Sakuma M; Yasuda K; Tanabe T; Sakurai M
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Apr; 41(4):531-6. PubMed ID: 8515150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New technologies of internal defibrillation.
    Dosdall DJ; Ideker RE
    J Interv Card Electrophysiol; 2005 Aug; 13 Suppl 1():67-70. PubMed ID: 16133858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and limitations of treatment of ventricular fibrillation/ventricular tachycardia storm by subcutaneous implantable cardioverter defibrillator.
    Nagra B; Awan MU; Miriyala V; Kantharia BK
    Int J Cardiol; 2016 Nov; 222():978-979. PubMed ID: 27529389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.